Ing Groep Nv 10x Genomics, Inc. Transaction History

Ing Groep Nv

$14.2 Billion
Q4 2024

A detailed history of Ing Groep Nv transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Ing Groep Nv holds 75,400 shares of TXG stock, worth $851,265. This represents 0.01% of its overall portfolio holdings.

Number of Shares

75,400

Holding current value

$851,265

% of portfolio

0.01%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2024 Feb 03, 2025	BUY	$13.18 - $21.31 $993,772 - $1.61 Million	75,400 New	75,400 $1.08 Million
Q1 2024 May 10, 2024	BUY	$36.08 - $54.3 $1.67 Million - $2.52 Million	46,400 New	46,400 $1.74 Million

Others Institutions Holding TXG

# of Institutions

302

Shares Held

96.5M

Call Options Held

76.4K

Put Options Held

132K

Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

11.9M
Shares

$135 Million
1.5% of portfolio
Vanguard Group Inc Valley Forge, PA

10.9M
Shares

$123 Million
0.0% of portfolio
Black Rock Inc. New York, NY

6.39M
Shares

$72.2 Million
0.0% of portfolio
Nikko Asset Management Americas, Inc.

5.71M
Shares

$64.5 Million
0.92% of portfolio
Sumitomo Mitsui Trust Holdings, Inc.

5.71M
Shares

$64.5 Million
0.06% of portfolio

View Full List

About 10x Genomics, Inc.

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.07B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

More about TXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ing Groep Nv, based on Form 13F filings with the SEC.

News

Stay updated on Ing Groep Nv with notifications on news.

Account